More than six decades after chemist Calvin Stevens first synthesized ketamine in the laboratories of Parke-Davis—an endeavor...
Treatment Innovations
In a strategic move to cement its position in the rapidly evolving landscape of orthopaedic surgery, California-based...
The Evolution of Precision Oncology: Merck’s Calderasib and the Future of KRAS-Driven Cancer Therapy
The Evolution of Precision Oncology: Merck’s Calderasib and the Future of KRAS-Driven Cancer Therapy
For decades, the KRAS gene—a central conductor of cellular signaling—was deemed "undruggable." Its structural composition, characterized by...
Johnson & Johnson (J&J), the global healthcare conglomerate, has released its second-quarter financial results for 2026, painting...
In the high-stakes world of biopharmaceutical manufacturing, the bridge between laboratory discovery and commercial-scale production is often...
In a landmark development for the medical sector in New York, GE HealthCare and Catholic Health have...
For decades, the pharmaceutical industry has operated under the weight of the "Eroom’s Law"—a phenomenon where drug...
In a significant milestone for neurovascular medicine, medical technology firm RapidPulse has successfully closed a $48 million...
The biotechnology sector is currently navigating a complex convergence of high-stakes intellectual property litigation and rapid clinical...
In a move set to reshape the landscape of oral drug delivery, AustinPx—a Texas-based contract development and...
